[1]
Stein Gold, L., Lebwohl, M., Bhatia, N. , DiRuggiero, D., Jacobson, A. and Pillai, R. 2020. Long-Term Management of Moderate-to-Severe Plaque Psoriasis: Maintenance of Treatment Success Following Cessation of Halobetasol Propionate 0.01%/Tazarotene 0.045% Lotion. SKIN The Journal of Cutaneous Medicine. 4, 6 (Oct. 2020), s79. DOI:https://doi.org/10.25251/skin.4.supp.79.